- Scrip Originals
- Featured Topics
Already a Biomedtracker subscriber? You have access to the full company record through your subscription
Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Visirna Therapeutics
The US- and China-based biotech is expanding three oncology-centered clinical studies of two TGF-1/COX-2-targeted siRNA drug candidates from the US into China.
- Antisense, Oligonucleotides